NM_003476.5:c.172T>G
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_003476.5(CSRP3):c.172T>G(p.Cys58Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. C58C) has been classified as Likely benign.
Frequency
Consequence
NM_003476.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD, SD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
- hypertrophic cardiomyopathy 12Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- dilated cardiomyopathy 1MInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461086Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726844 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 12 Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
The p.C58G variant (also known as c.172T>G), located in coding exon 2 of the CSRP3 gene, results from a T to G substitution at nucleotide position 172. The cysteine at codon 58 is replaced by glycine, an amino acid with highly dissimilar properties. This variant was identified in one or more individuals with features consistent with hypertrophic cardiomyopathy and segregated with disease in at least one family (Geier C et al. Circulation, 2003 Mar;107:1390-5; Geier C et al. Hum. Mol. Genet., 2008 Sep;17:2753-65). An animal model expressing this variant exhibited phenotype(s) consistent with CSRP3-related hypertrophic cardiomyopathy. In multiple assays testing CSRP3 function, this variant showed functionally abnormal results (Geier C et al. Circulation, 2003 Mar;107:1390-5; Geier C et al. Hum. Mol. Genet., 2008 Sep;17:2753-65; Ehsan M et al. J. Mol. Cell. Cardiol., 2018 Aug;121:287-296). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is interpreted as a disease-causing mutation; however, in the heterozygous state, this variant may present with reduced penetrance and expressivity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at